GlaxoSmithKline slashes AIDS drug prices

October 28, 2003
Sales and Marketing

GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and …

International performance keeps BMS afloat

October 28, 2003
Sales and Marketing

International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the …

Government proposes ‘clinical exceptions’ to A&E targets

October 28, 2003

The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect …

Money Syner buy-out to create UK’s biggest healthcare agency

October 28, 2003

Global healthcare communications agency Euro RSCG Life has acquired Money Syner Communications to create what it says will be the …

Pfizer spots potential of Organon atypical antipsychotic

October 28, 2003

Pfizer is  to co-develop and promote a promising new atypical antipsychotic discovered by Dutch pharma company Organon.Under the terms of …

Swiss pharma companies beat expecations

October 28, 2003

Switzerland's number one pharmaceutical company Novartis has reported a sharp rise in sales in the first nine months of the …

Atypical anti-psychotics to get diabetes warning in US

October 28, 2003

All atypical anti-psychotic drugs are to carry warnings on their US labels about potentially fatal hyperglycaemia side-effects and increased risk …

Job cuts at Merck

October 28, 2003

US pharma giant Merck is to make 4,400 redundancies in an effort to stem falling profits, following a 7% drop …

Novartis Cox-II contender approved in UK

October 28, 2003

A new rival to blockbuster Cox-II inhibitor drugs from Pfizer and Merck Sharp & Dohme has been approved in the …

Restructure unveiled as Pfizer takes merger hit

October 28, 2003

Pfizer has unveiled a restructuring of its business to maximise its R&D and marketing might following the acquisition of Pharmacia …

New company to capitalise on industry M&A activity

October 28, 2003

A new private European pharma company has been launched that will exploit products made available through the spate of industry …

AstraZeneca targets Canadian parallel imports

October 28, 2003

AstraZeneca has become the second major pharma company to limit sales of drugs to Canada in a bid to curb …

New guidelines for industry ‘disease awareness’ campaigns

October 28, 2003

Pharmaceutical industry 'disease awareness campaigns' aimed at UK consumers are to be governed by new guidelines to formalise the practice …

The Gateway to Local Adoption Series

Latest content